These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980. Bravi D; Davis TL; Mouradian MM; Chase TN Mov Disord; 1993 Apr; 8(2):195-7. PubMed ID: 8097280 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease]. Jiménez-Jiménez FJ; Molina JA; Ortí-Pareja M Rev Neurol; 1999 May 1-15; 28(9):889-98. PubMed ID: 10390756 [TBL] [Abstract][Full Text] [Related]
7. Update on antiparkinsonian agents. Weiner M Geriatrics; 1982 Sep; 37(9):81-4, 89-91. PubMed ID: 6125455 [No Abstract] [Full Text] [Related]
9. [Reconsiderations in the treatment of Parkinson's disease with levodopa: some pharmacodynamic evidence]. Zappia M; Nicoletti A; Muñoz-S D; Tapia-Núñez J Rev Neurol; 2009 Jul 1-15; 49(1):33-40. PubMed ID: 19557698 [TBL] [Abstract][Full Text] [Related]
10. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists. Kondo T J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060 [TBL] [Abstract][Full Text] [Related]
11. [Arguments in favor of the early treatment of Parkinson's disease with L-Dopa]. Broussolle E Rev Neurol (Paris); 1999 Jan; 155(1):27-33. PubMed ID: 10093845 [No Abstract] [Full Text] [Related]
12. [Current problems of drug treatment of Parkinson disease]. Kuran W Neurol Neurochir Pol; 1980; 14(4):427-35. PubMed ID: 7412998 [No Abstract] [Full Text] [Related]
18. Cascade of levodopa dose and weight-related dyskinesia in Parkinson's disease (LD-WD-PD cascade). Sharma JC; Macnamara L; Hasoon M; Vassallo M; Ross I Parkinsonism Relat Disord; 2006 Dec; 12(8):499-505. PubMed ID: 16935018 [TBL] [Abstract][Full Text] [Related]
19. The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. Vidailhet M; Bonnet AM; Marconi R; Durif F; Agid Y Mov Disord; 1999; 14 Suppl 1():13-8. PubMed ID: 10493399 [No Abstract] [Full Text] [Related]
20. Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease. Fox S; Silverdale M; Kellett M; Davies R; Steiger M; Fletcher N; Crossman A; Brotchie J Mov Disord; 2004 May; 19(5):554-60. PubMed ID: 15133820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]